VT Bio Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • 2ndary - Private

VT Bio General Information

Description

Operator of a biotechnology company intended to develop new drugs to improve the quality of life for COPD (Chronic obstructive pulmonary disease) patients. The company offers therapies, medicines, and hair care products for dementia, depression, chronic obstructive pulmonary disease, diabetes, hair loss, hair growth, and the liver, among others, enabling individuals to improve the quality of life and welfare of mankind through aggressive commercialization.

Contact Information

Website
www.vtbio.co.kr
Formerly Known As
GMP Bio, GoodMedi, Purimed
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 301, 16, Samseong-ro 76-gil
  • Gangnam-gu
  • Seoul
  • South Korea
+82
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 301, 16, Samseong-ro 76-gil
  • Gangnam-gu
  • Seoul
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VT Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Jul-2025 Completed Generating Revenue
2. Later Stage VC 01-Jan-2018 Completed Generating Revenue
1. Seed Round Completed Startup
To view VT Bio’s complete valuation and funding history, request access »

VT Bio Patents

VT Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4403179-A1 Pharmaceutical composition containing regulatory t cells as active ingredient for preventing or treating degenerative brain diseases Inactive 13-Sep-2021
EP-4403179-A4 Pharmaceutical composition containing regulatory t cells as active ingredient for preventing or treating degenerative brain diseases Inactive 13-Sep-2021
US-20240293542-A1 Pharmaceutical composition containing regulatory t cells as active ingredient for preventing or treating degenerative brain diseases Pending 13-Sep-2021
WO-2023038489-A1 Pharmaceutical composition containing regulatory t cells as active ingredient for preventing or treating degenerative brain diseases Inactive 13-Sep-2021
JP-2024535130-A Pharmaceutical composition for preventing or treating degenerative brain diseases containing regulatory t cells as an active ingredient Pending 13-Sep-2021 A61K35/17
To view VT Bio’s complete patent history, request access »

VT Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VT Bio FAQs

  • When was VT Bio founded?

    VT Bio was founded in 2000.

  • Where is VT Bio headquartered?

    VT Bio is headquartered in Seoul, South Korea.

  • What is the size of VT Bio?

    VT Bio has 3 total employees.

  • What industry is VT Bio in?

    VT Bio’s primary industry is Biotechnology.

  • Is VT Bio a private or public company?

    VT Bio is a Private company.

  • What is VT Bio’s current revenue?

    The current revenue for VT Bio is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process